These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 18686123)

  • 1. Membrane-specific antibodies induced by liposomes can simultaneously bind to HIV-1 protein, peptide, and membrane lipid epitopes.
    Beck Z; Karasavvas N; Matyas GR; Alving CR
    J Drug Target; 2008 Aug; 16(7):535-42. PubMed ID: 18686123
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antibodies induced by liposomal protein exhibit dual binding to protein and lipid epitopes.
    Karasavvas N; Beck Z; Tong J; Matyas GR; Rao M; McCutchan FE; Michael NL; Alving CR
    Biochem Biophys Res Commun; 2008 Feb; 366(4):982-7. PubMed ID: 18088597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neutralizing antibodies induced by liposomal HIV-1 glycoprotein 41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes.
    Matyas GR; Wieczorek L; Beck Z; Ochsenbauer-Jambor C; Kappes JC; Michael NL; Polonis VR; Alving CR
    AIDS; 2009 Oct; 23(16):2069-77. PubMed ID: 19710597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural details of HIV-1 recognition by the broadly neutralizing monoclonal antibody 2F5: epitope conformation, antigen-recognition loop mobility, and anion-binding site.
    Julien JP; Bryson S; Nieva JL; Pai EF
    J Mol Biol; 2008 Dec; 384(2):377-92. PubMed ID: 18824005
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Liposomal formulations of synthetic MUC1 peptides: effects of encapsulation versus surface display of peptides on immune responses.
    Guan HH; Budzynski W; Koganty RR; Krantz MJ; Reddish MA; Rogers JA; Longenecker BM; Samuel J
    Bioconjug Chem; 1998; 9(4):451-8. PubMed ID: 9667946
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-1, lipid rafts, and antibodies to liposomes: implications for anti-viral-neutralizing antibodies.
    Alving CR; Beck Z; Karasavva N; Matyas GR; Rao M
    Mol Membr Biol; 2006; 23(6):453-65. PubMed ID: 17127618
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipid A and liposomes containing lipid A as antigens and adjuvants.
    Alving CR; Rao M
    Vaccine; 2008 Jun; 26(24):3036-45. PubMed ID: 18226433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The immunogenic CBD1 peptide corresponding to the caveolin-1 binding domain in HIV-1 envelope gp41 has the capacity to penetrate the cell membrane and bind caveolin-1.
    Benferhat R; Sanchez-Martinez S; Nieva JL; Briand JP; Hovanessian AG
    Mol Immunol; 2008 Apr; 45(7):1963-75. PubMed ID: 18054388
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid modulation of membrane-bound epitope recognition and blocking by HIV-1 neutralizing antibodies.
    Huarte N; Lorizate M; Kunert R; Nieva JL
    FEBS Lett; 2008 Nov; 582(27):3798-804. PubMed ID: 18930052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct mechanisms of lipid bilayer perturbation induced by peptides derived from the membrane-proximal external region of HIV-1 gp41.
    Apellániz B; Nir S; Nieva JL
    Biochemistry; 2009 Jun; 48(23):5320-31. PubMed ID: 19449801
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of the HIV-1 gp41 core-binding motif--HXXNPF.
    Huang JH; Liu ZQ; Liu S; Jiang S; Chen YH
    FEBS Lett; 2006 Sep; 580(20):4807-14. PubMed ID: 16904109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Calcium modulation of monoclonal antibody binding to phosphatidylinositol phosphate.
    Beck Z; Karasavvas N; Tong J; Matyas GR; Rao M; Alving CR
    Biochem Biophys Res Commun; 2007 Mar; 354(3):747-51. PubMed ID: 17257584
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interactions of HIV-1 antibodies 2F5 and 4E10 with a gp41 epitope prebound to host and viral membrane model systems.
    Veiga AS; Pattenden LK; Fletcher JM; Castanho MA; Aguilar MI
    Chembiochem; 2009 Apr; 10(6):1032-44. PubMed ID: 19283693
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antigen-specific enhancement of natural human IgG antibodies to phosphatidylcholine, phosphatidylglycerol, phosphatidylinositol-4-phosphate, cholesterol, and lipid A by a liposomal vaccine containing lipid A.
    Matyas GR; Alving CR
    Vaccine; 2011 Jul; 29(32):5137-44. PubMed ID: 21624414
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The caveolin-1 binding domain of HIV-1 glycoprotein gp41 (CBD1) contains several overlapping neutralizing epitopes.
    Benferhat R; Krust B; Rey-Cuillé MA; Hovanessian AG
    Vaccine; 2009 Jun; 27(27):3620-30. PubMed ID: 19464543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The CBD1 peptide corresponding to the caveolin-1 binding domain of HIV-1 glycoprotein gp41 elicits neutralizing antibodies in cynomolgus macaques when administered with the tetanus T helper epitope.
    Benferhat R; Martinon F; Krust B; Le Grand R; Hovanessian AG
    Mol Immunol; 2009 Feb; 46(4):705-12. PubMed ID: 19010547
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Specific phospholipid recognition by human immunodeficiency virus type-1 neutralizing anti-gp41 2F5 antibody.
    Sánchez-Martínez S; Lorizate M; Hermann K; Kunert R; Basañez G; Nieva JL
    FEBS Lett; 2006 Apr; 580(9):2395-99. PubMed ID: 16616522
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The influence of cholesterol on the interaction of HIV gp41 membrane proximal region-derived peptides with lipid bilayers.
    Veiga AS; Castanho MA
    FEBS J; 2007 Oct; 274(19):5096-104. PubMed ID: 17803684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The binding of HIV-1 gp41 membrane proximal domain to its mucosal receptor, galactosyl ceramide, is structure-dependent.
    Yu H; Alfsen A; Tudor D; Bomsel M
    Cell Calcium; 2008 Jan; 43(1):73-82. PubMed ID: 17553560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of cholesterol on the interaction of the HIV GP41 fusion peptide with model membranes. Importance of the membrane dipole potential.
    Buzón V; Cladera J
    Biochemistry; 2006 Dec; 45(51):15768-75. PubMed ID: 17176099
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.